Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

100 Percent Owned Zinc-Copper Project

Murchison Minerals is a well funded company with its main asset located in Saskatchewan. Their 100 percent owned, high grade, zinc-copper project has an indicated and inferred resource with exploration upside and excellent access to infrastructure. Mu...

E-Power Resources: developing graphite resources for the emerging EV market

E-Power Resources is dedicated to exploring for mineral resources in Quebec. The Montreal-based exploration firm is on the lookout for commercial exploitation opportunities. Its current focus is on the key EV battery metal, graphite. The Market Herald recently cha...

Xali Gold: advancing gold and silver assets in Mexico and Peru

Our company today is dedicated to being a responsible community partner. Xali Gold plans to advance its gold and silver assets internally and with industry partners. El Oro is the company’s flagship asset, home to a well-known prolific high-grade gold-silv...

Marinus Pharma Shares Open Up 41% on Phase 2 Epilepsy Trial Results

Marinus Pharmaceuticals reported positive top-line results for ganaxolone in its Phase 2 refractory status epilepticus trial with all patients achieving the primary endpoint. This morning Marinus Pharmaceuticals Inc. (MRNS:NASDAQ) , a pharmaceutical firm dedicated to...

Theralase is raising up to $5.3M to complete bladder cancer study

Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...

Bringing Hope to People Living with Neurodegenerative Diseases

Alpha Cognition Inc. ( TSX-V.ACOG , OTCMKTS: ACOGF , Forum ) is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases. Stockhouse Media’s Dave Jackson caught up recently with Company CE...

Introducing the ‘Better Quality, Better Serviced” Video Conferencing Platform

(Click image to play video) Simplified video conferencing across any device means exceptional usability. Enhanced security settings ensure continuous meeting time, encryption, role-based security and password protection. Introducing Fuzion – providing one integ...

dynaCERT Invited to Speak at World Climate Summit on Future of World Carbon Credits, ...

dynaCERT Invited to Speak at World Climate Summit on Future of World Carbon Credits, Sales Growing Exponentially dynaCERT Inc. (TSX-V: DYA) (OTCQB: DYFSF) (Frankfurt: DMJ) CEO & President, Jim Payne, was interviewed on Bloomberg BNN (Business News Network) this week in...

Revolutionizing vascular grafting with a durable solution

Our next guest is a multi-technology biomedical company, focused on the development and commercialization of medical technologies. Marizyme Inc. (OTCQB:MRZM) has had its sights set on development of medical technology and products, one of which is DuraGraft. J...

Meet The First Publicly Traded Company Focused on Exposure to Altcoins and DeFi

Although bitcoin is still the leader in cryptocurrencies, altcoins are surging in prominence as top ones such as Ethereum and Litecoin continue to rise to the forefront. Altcoins are exactly what they sound like: alternative cryptocurrencies to bitcoin although they sha...
1 2 3 4 5 6 7 8 9 10 ...